Skip to content
Search

Latest Stories

After Robbie Turner, Gail Fleming leaves RPS

Gail Fleming, the director of Education and Professional Development at the Royal Pharmaceutical Society, has decided to resign. Thursday, April 7 will be her last day at the RPS.

In a statement, chief executive Paul Bennett said: “On the 4th March we announced that we were proposing some changes to our executive structure.


“Further to my update on the 24th of March I can announce that Gail Fleming has decided to leave her role as Director of Education and Professional Development and her last day with us will be 07 April 2022."

Bennett wished Fleming luck and thanked "her for her excellent work since joining the organisation in 2018".

He added: “I will be updating everyone on how any changes to our structure enable us to deliver our Royal Charter obligations and our five-year strategy.”

Robbie Turner Robbie Turner

Last week, RPS also announced that "Robbie Turner has decided to leave his role as director of Pharmacy and Membership Experience and his last day with us will be 31 March 2022."

Earlier, on a proposed change to the executive structure, RPS president Claire Anderson commented: “I deeply regret seeing so much speculation in the public domain about a proposed change to the Executive Team when no decision has yet been made, and feel for those involved.

“This is an organisational decision, as it is about operational matters. RPS finances are on a secure footing and this proposal is not about cost savings. We intend to continue our investment in education and professional leadership for the future of the pharmacy profession.

“Our excellent and dedicated teams will continue to advocate on behalf of the profession across all sectors and areas of practice, including education, workforce issues, independent prescribing and inclusion and diversity.

"In particular, our work on education, including post-registration curricula, assessment and credentialing, workforce planning, leadership development and mentoring are strategically important to our profession, right from undergraduate level through foundation to advanced and consultant practice.

"We are completely committed to maintaining this work and should the proposal go ahead, there would still be a leader on the Executive with responsibility for delivering on our education strategy."

In March, RPS said that it had identified two roles at potential risk of redundancy, but did not specify which two roles were going to be axed.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less